The Ever-Changing World of Extractables and Leachables: Lessons learned and future challenges



October 4, 2021 at 3pm BST | 10am EST | 4pm CEST Join global industry and regulatory experts as they discuss current hot topics in extractables and leachables (E&L) testing for pharmaceuticals, biopharmaceuticals and medical devices.

Register Free:

Event Overview:

Join global industry and regulatory experts as they discuss current extractables and leachables (E&L) hot topics on pharmaceuticals, biopharmaceuticals, and medical devices. Extractables and leachables are an important consideration when developing medical products and devices. This conference will give you an insight into a number of different topics within the ever-changing world of E&L.

Key Learning Objectives:

  • Gain insight to some of the important E&L areas for medical devices and pharmaceutical products
  • Learn about some of the key challenges within the field of E&L
  • Understand the science behind the testing

Who Should Attend:

  • Representatives from the supply chain to pharma, biopharma, and medical devices
  • Members of the medical and medicinal product world wanting to know more about the challenges with E&L
  • Those new to the field of E&L wanting to learn some key aspects of the requirements


ISO 10993-18: Establishing an AET for Chemical Characterization of Medical Devices

Ted Heise, PhD, RAC – MED Institute, Managing Partner &Toxicologist, D&B ChemTox, LLC

E&L in Biological Combination Products

Alicja Sobantka, PhD, Material Qualification, Octapharma

Managing Change in This Rapidly Changing World of Extractables and Leachables

Nick Morley, Principal Scientist, Hall Analytical

Strategies to Overcome Challenges in Extractable Screening Studies

Rachel Sanig, Senior Scientist, Waters Corporation

What is the Future of Leachables and Extractables Assessment?

Dan Norwood, Principal Consultant, Feinberg Norwood & Associates Pharma Consulting

What next for E&L?- Data, Information, Knowledge to Wisdom

Jason Creasey, Managing Director, Maven E&L Ltd


Qualification of screening methods, how is this achieved?


Andrew Feilden
European E&L Strategic Director
Hall Analytical

Ted Heise, PhD
RAC – MED Institute, Managing Partner & Toxicologist
D&B ChemTox, LLC

Alicja Sobantka, PhD
Material Qualification

Nick Morley
Principal Scientist
Hall Analytical

Rachel Sanig
Senior Scientist
Waters Corporation

Dan Norwood
Principal Consultant
Feinberg Norwood & Associates Pharma Consulting

Jason Creasey
Managing Director
Maven E&L Ltd


Hall Analytical
VR Analytical

Register Free:

Related Content